Abstract
This report details the current and projected market for wound management
products, including dressings, closure devices, debridement, pharmacological
products, tissue engineered products and others. Particular emphasis is placed
on advanced and leading edge developments (i.e., those approaching wound
management from novel perspective) such as growth factors, stem cells, gene
therapy and other approaches, while baseline data (current and forecast market
size and current competitor market shares) is provided for established
segments -- multiple dressings types (film, foam, alginate, antibacterial,
non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical
treatments. The report details the clinical and technology developments
underlying this huge and evolving worldwide market, with data on products in
development and on the market; market size and forecast; competitor market
shares; competitor profiles; and market opportunity. Separate size, growth
and competitor data are presented for the U.S., leading western European
countries, Japan and the Rest of World category. The report profiles leading
and emerging companies, with profiles providing detailed profile information
on major competitors, brief profiles of companies with less sizeable current
or potential positions in the market, and additional profiles of companies
with novel or advanced research activities in the market.
The report establishes the current worldwide market size for major technology
segments as a baseline for and projecting growth in the market over a ten-year
forecast and assesses and projects the composition of the market as
technologies gain or lose relative market performance over this period.
| 
View Cart
